Skip to content

Studying the Effectiveness of a Herbal Unani Medicine for Chronic Pharyngitis.

Evaluation of the efficacy of polyherbal Unani formulations in the management of Waram-i-Halq Muzmin (chronic pharyngitis): An open-label, single-arm study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098508
Enrollment
44
Registered
2025-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J312- Chronic pharyngitis

Interventions

Intervention1: Joshanda of Behdana Unnab Sapistan with Sharbat Toot Siyah: sixty milliliter Joshanda with two tola Sharbat Toot Siyah twice daily for 45 days. Control Intervention1: nil: nil

Sponsors

State Unani Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants aged eighteen years to sixty five years of either gender Clinically diagnosed cases of waram i halq muzmin Presence of symptoms such as sore throat dry throat or pharyngeal itching along with clinical signs including pharyngeal mucosal edema mucosal congestion or stasis of secretions persisting for more than three weeks Mild to moderate disease severity based on clinical assessment with absolute eosinophil count less than five thousand per millimeter cube Participants willing to provide written informed consent and comply with the study protocol for the entire study duration

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Known cases of renal hepatic or cardiac ailments or diabetes mellitus Participants who have taken antibiotics or other medications for chronic pharyngitis within the past fifteen days Chronic pharyngitis with complications as assessed clinically or radiologically Participants who do not provide written informed consent

Design outcomes

Primary

MeasureTime frame
Change in AECTimepoint: At Baseline At 30 days At 45 day

Secondary

MeasureTime frame
Evaluation of Quality of Life using a validated questionnaire a disease specific QoL scaleTimepoint: At Baseline At 45 days

Countries

India

Contacts

Public ContactNazar Hasan

State Unani Medical College and Hospital

arogyaherbal@gmail.com9415639877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026